BeOne Medicines(DE:49BA)
€376.00+2.00 (+0.53%)
DE:49BA
BeOne Medicines earnings date
€376.00
At close:+2.00 (+0.53%)
BeOne Medicines (49BA) Q2 2023 Earnings Report
4 Followers
DE:49BA Q2 2023 EPS Results
- Actual EPS
- -EUR 3.30
- Consensus EPS
- -EUR 3.05
- Beat/Miss
- Missed by -EUR 0.25
- One Year Ago EPS
- -EUR 5.04
DE:49BA Q2 2023 Revenue Results
- Actual Revenue
- EUR 533.86M
- Expected Revenue
- EUR 454.54M
- Beat/Miss
- Beat by +EUR 79.32M
- YoY Revenue Growth
- +73.15%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/25/2023
- Time
- TBA
- Conference Call
- Friday, August 25, 2023
DE:49BA Upcoming Earnings
BeOne Medicines's next earnings date is estimated for March 31, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:49BA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 31, 2027 | 2026 (Q4) | 2.34- | 0.54 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | 1.722.95 | 0.99 | 198.17% (+1.96) | |
| Aug 05, 2026 | 2026 (Q2) | 1.511.86 | 0.83 | 125.27% (+1.03) | |
| May 06, 2026 | 2026 (Q1) | 0.881.78 | 0 | ― | |
| Feb 26, 2026 | 2025 (Q4) | 1.130.54 | -1.3 | 141.96% (+1.84) | |
| Nov 06, 2025 | 2025 (Q3) | 0.770.99 | -1.04 | 194.78% (+2.03) | |
| Aug 06, 2025 | 2025 (Q2) | 0.350.83 | -1.04 | 179.13% (+1.87) | |
| May 07, 2025 | 2025 (Q1) | -0.520.00 | -2.19 | 100.00% (+2.19) | |
| Feb 27, 2025 | 2024 (Q4) | -0.92-1.30 | -3.2 | 59.49% (+1.91) | |
| Nov 12, 2024 | 2024 (Q3) | -1.01-1.04 | 1.82 | -157.21% (-2.87) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
